The above chart presents the market trend analysis for humax pharmaceutical s.a. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 27 transactions, with a transaction quantity of 19219.86 and a transaction weight of 19213.86.
5bausch health
united statesbuyer,they trade on 2021-09-22
2523.91%
>
+View All
Products
Total 95
ProductsTransactionsPerDetail
equipped with fixed dose drug 6215.58%>
heterocyclic compounds with nitrogen hetero-atom 287.04%>
nucleic acids 235.78%>
itrogen containing heterocyclic compounds other atoms 215.28%>
animal blood 184.52%>
+View All
Hscode rank
Total 319
HSCode NameTransactionsPerDetail
HS 30049029006215.58%>
HS 38229000004611.56%>
HS 2934999000235.78%>
HS 2933999000215.28%>
HS 3002909000184.52%>
+View All
Trading Area
Total 33
AreaTransactionsPerDetail
india109917.07%>
costa rica109517.01%>
united states73211.37%>
other5338.28%>
mexico3275.08%>
+View All
Port statistics
Total 11
Port NameTransactionsPerDetail
bogota69510.80%>
medellin871.35%>
aduanas de medellin130.20%>
buenaventura120.19%>
houston90.14%>
+View All
humax pharmaceutical s.a. is colombia Buyer&Supplier,
and primarily engages in the import and export business of products such as equipped with fixed dose drug,heterocyclic compounds with nitrogen hetero-atom,nucleic acids.
According to the 52wmb.com global trade database, as of 2026-02-24, the company has completed 6438 international trades,
with its main trading regions covering india,costa rica,united states etc.
The core products include HS3004902900,HS3822900000,HS2934999000 etc,
often transported via bogota,port medellin, port aduanas de medellin etc,
and its main trading partners are bausch health ireland ltd.,bausch y lomb mexico s.a.de c.v.,zeillock inc..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on humax pharmaceutical s.a. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.